Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B

Gene therapy developed at St. Jude Children's Research Hospital, University College London (UCL) and the Royal Free Hospital has transformed life for men with a severe form of hemophilia B by providing a safe, reliable source of the blood clotting protein Factor IX that has allowed some to adopt a more active lifestyle, researchers reported. The results appear in the November 20 edition of The New England Journal of Medicine.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews